Coronavirus | China gives go-ahead for human trials of COVID-19 vaccine

Researchers will do tests on 108 healthy persons

Updated - December 03, 2021 06:49 am IST

Published - March 17, 2020 11:01 pm IST - Beijing

In this photo released by Xinhua News Agency, Chinese President Xi Jinping, second right, wearing a protective face mask, talks to a medical staff members during his visit to the Academy of Military Medical Sciences in Beijing, Monday, March 2, 2020. The number of new virus infections rose worldwide along with fears of a weakening global economy, even as cases in China dropped to their lowest level in six weeks on Monday and hundreds of patients at the outbreak's epicenter were released from hospitals. (Ju Peng/Xinhua via AP)

In this photo released by Xinhua News Agency, Chinese President Xi Jinping, second right, wearing a protective face mask, talks to a medical staff members during his visit to the Academy of Military Medical Sciences in Beijing, Monday, March 2, 2020. The number of new virus infections rose worldwide along with fears of a weakening global economy, even as cases in China dropped to their lowest level in six weeks on Monday and hundreds of patients at the outbreak's epicenter were released from hospitals. (Ju Peng/Xinhua via AP)

China has given the go-ahead for researchers to begin human safety tests of an experimental coronavirus vaccine in the race to develop a shot against the COVID-19 epidemic that has killed more than 7,000 people worldwide. Researchers at China’s Academy of Military Medical Sciences, affiliated to the Chinese People’s Liberation Army (PLA), received approval to launch early-stage clinical trials of the potential vaccine starting this week, the ruling Communist Party’s People’s Daily reported on Tuesday.

Scientists in the United States said on Monday that clinical trials had begun for a vaccine developed by its National Institute of Allergy and Infectious Diseases and the U.S. biotech firm Moderna.

Coronavirus | U.S. begins clinical trial of investigational vaccine

Details in the Chinese clinical trial registration database show that a “Phase 1” test that will examine whether experimental shot is safe in humans aims to recruit 108 healthy people.

The volunteers will take part in the study to take place between March 16 and December 31.

The trial will be conducted by China’s Academy of Military Medical Sciences and the Hong Kong-listed biotech firm CanSino Biologics, the database showed.

 

Experts at the World Health Organization say they do not expect any fully tested and approved vaccine to reach the market until the middle of next year.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.